Expression and activation of the reprogramming transcription factors

Biochemical and Biophysical Research Communications

Volumn 390, Issue 4, 2009, Pages 1081-1086

  Guo, Jun ^a,b   Li, Zi cheng ^a   Feng, Ying hong ^b  

^a JINAN UNIVERSITY   (China)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Expression; Reprogramming

Indexed keywords

CELL NUCLEUS RECEPTOR; DNA; KRUPPEL LIKE FACTOR 4; LIN28 PROTEIN; MICRORNA; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; RIBONUCLEASE III; SALL4 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; WNT PROTEIN;

DNA DAMAGE; EPIGENETICS; GENE; GENE STRUCTURE; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; REGULATORY MECHANISM; SHORT SURVEY; STIMULUS; STRESS;

ANIMALS; CELL DIFFERENTIATION; EPIGENESIS, GENETIC; HUMANS; MICE; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELLS; TRANSCRIPTION FACTORS;

IPS;

EID: 70450280575     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.11.017     Document Type: Short Survey

References (60)

1. Nishikawa S. Reprogramming by the numbers. Nat. Biotechnol. 25 (2007) 877-878
2. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
3. Wernig M., Meissner A., Foreman R., Brambrink T., Ku M., Hochedlinger K., et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448 (2007) 318-324
4. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007) 861-872
5. Maherali N., Sridharan R., Xie W., Utikal J., Eminli S., Arnold K., et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1 (2007) 55-70
6. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318 (2007) 1917-1920
7. Hanna J., Wernig M., Markoulaki S., Sun C.W., Meissner A., Cassady J.P., et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318 (2007) 1920-1923
8. Kim J., Chu J., Shen X., Wang J., and Orkin S.H. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132 (2008) 1049-1061
9. Zhao X.Y., Li W., Lv Z., Liu L., Tong M., Hai T., et al. IPS cells produce viable mice through tetraploid complementation. Nature 461 (2009) 86-90
10. Nichols J., Zevnik B., Anastassiadis K., Niwa H., Klewe-Nebenius D., Chambers I., et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95 (1998) 379-391
11. Herr W., Sturm R.A., Clerc R.G., Corcoran L.M., Baltimore D., Sharp P.A., et al. The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. Genes Dev. 2 (1988) 1513-1516
12. Pesce M., and Scholer H.R. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 19 (2001) 271-278
13. Kamachi Y., Uchikawa M., and Kondoh H. Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet. 16 (2000) 182-187
14. Avilion A.A., Nicolis S.K., Pevny L.H., Perez L., Vivian N., and Lovell-Badge R. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 17 (2003) 126-140
15. Yuan H., Corbi N., Basilico C., and Dailey L. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev. 9 (1995) 2635-2645
16. Nishimoto M., Fukushima A., Okuda A., and Muramatsu M. The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2. Mol. Cell. Biol. 19 (1999) 5453-5465
17. Ben-Shushan E., Thompson J.R., Gudas L.J., and Bergman Y. Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site. Mol. Cell. Biol. 18 (1998) 1866-1878
18. Tokuzawa Y., Kaiho E., Maruyama M., Takahashi K., Mitsui K., Maeda M., et al. Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem cell self-renewal and mouse development. Mol. Cell. Biol. 23 (2003) 2699-2708
19. Okumura-Nakanishi S., Saito M., Niwa H., and Ishikawa F. Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic stem cells. J. Biol. Chem. 280 (2005) 5307-5317
20. Catena R., Tiveron C., Ronchi A., Porta S., Ferri A., Tatangelo L., et al. Conserved POU binding DNA sites in the Sox2 upstream enhancer regulate gene expression in embryonic and neural stem cells. J. Biol. Chem. 279 (2004) 41846-41857
21. Sato N., Meijer L., Skaltsounis L., Greengard P., and Brivanlou A.H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 10 (2004) 55-63
22. Ogawa K., Nishinakamura R., Iwamatsu Y., Shimosato D., and Niwa H. Synergistic action of Wnt and LIF in maintaining pluripotency of mouse ES cells. Biochem. Biophys. Res. Commun. 343 (2006) 159-166
23. Takao Y., Yokota T., and Koide H. Beta-catenin up-regulates Nanog expression through interaction with Oct-3/4 in embryonic stem cells. Biochem. Biophys. Res. Commun. 353 (2007) 699-705
24. Niwa H., Miyazaki J., and Smith A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24 (2000) 372-376
25. Kopp J.L., Ormsbee B.D., Desler M., and Rizzino A. Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells 26 (2008) 903-911
26. Gu P., Goodwin B., Chung A.C., Xu X., Wheeler D.A., Price R.R., et al. Orphan nuclear receptor LRH-1 is required to maintain Oct4 expression at the epiblast stage of embryonic development. Mol. Cell. Biol. 25 (2005) 3492-3505
27. Barnea E., and Bergman Y. Synergy of SF1 and RAR in activation of Oct-3/4 promoter. J. Biol. Chem. 275 (2000) 6608-6619
28. Fuhrmann G., Chung A.C., Jackson K.J., Hummelke G., Baniahmad A., Sutter J., et al. Mouse germline restriction of Oct4 expression by germ cell nuclear factor. Dev. Cell 1 (2001) 377-387
29. Park S.W., Hu X., Gupta P., Lin Y.P., Ha S.G., and Wei L.N. SUMOylation of Tr2 orphan receptor involves Pml and fine-tunes Oct4 expression in stem cells. Nat. Struct. Mol. Biol. 14 (2007) 68-75
30. Ben-Shushan E., Sharir H., Pikarsky E., and Bergman Y. A dynamic balance between ARP-1/COUP-TFII, EAR-3/COUP-TFI, and retinoic acid receptor:retinoid X receptor heterodimers regulates Oct-3/4 expression in embryonal carcinoma cells. Mol. Cell. Biol. 15 (1995) 1034-1048
31. Bernstein E., Kim S.Y., Carmell M.A., Murchison E.P., Alcorn H., Li M.Z., et al. Dicer is essential for mouse development. Nat. Genet. 35 (2003) 215-217
32. Kanellopoulou C., Muljo S.A., Kung A.L., Ganesan S., Drapkin R., Jenuwein T., et al. Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev. 19 (2005) 489-501
33. Paddison P.J., Caudy A.A., Bernstein E., Hannon G.J., and Conklin D.S. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16 (2002) 948-958
34. Cui X.S., Shen X.H., and Kim N.H. Dicer1 expression in preimplantation mouse embryos: involvement of Oct3/4 transcription at the blastocyst stage. Biochem. Biophys. Res. Commun. 352 (2007) 231-236
35. Chambers I., Colby D., Robertson M., Nichols J., Lee S., Tweedie S., et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113 (2003) 643-655
36. Mitsui K., Tokuzawa Y., Itoh H., Segawa K., Murakami M., Takahashi K., et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113 (2003) 631-642
37. Pan G., Li J., Zhou Y., Zheng H., and Pei D. A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal. FASEB J. 20 (2006) 1730-1732
38. Kuroda T., Tada M., Kubota H., Kimura H., Hatano S.Y., Suemori H., et al. Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol. Cell. Biol. 25 (2005) 2475-2485
39. Chen L., Yang M., Dawes J., and Khillan J.S. Suppression of ES cell differentiation by retinol (vitamin A) via the overexpression of Nanog. Differ.: Res. Biol. Divers. 75 (2007) 682-693
40. Freberg C.T., Dahl J.A., Timoskainen S., and Collas P. Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract. Mol. Biol. Cell 18 (2007) 1543-1553
41. Vanhaesebroeck B., Leevers S.J., Ahmadi K., Timms J., Katso R., Driscoll P.C., et al. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70 (2001) 535-602
42. Armstrong L., Hughes O., Yung S., Hyslop L., Stewart R., Wappler I., et al. The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum. Mol. Genet. 15 (2006) 1894-1913
43. Storm M.P., Bone H.K., Beck C.G., Bourillot P.Y., Schreiber V., Damiano T., et al. Regulation of Nanog expression by phosphoinositide 3-kinase-dependent signaling in murine embryonic stem cells. J. Biol. Chem. 282 (2007) 6265-6273
44. Wu Q., Chen X., Zhang J., Loh Y.H., Low T.Y., Zhang W., et al. Sall4 interacts with Nanog and co-occupies Nanog genomic sites in embryonic stem cells. J. Biol. Chem. 281 (2006) 24090-24094
45. Zhang J., Tam W.L., Tong G.Q., Wu Q., Chan H.Y., Soh B.S., et al. Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat. Cell Biol. 8 (2006) 1114-1123
46. Shields J.M., Christy R.J., and Yang V.W. Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J. Biol. Chem. 271 (1996) 20009-20017
47. Rowland B.D., Bernards R., and Peeper D.S. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat. Cell Biol. 7 (2005) 1074-1082
48. Liu Y., Wang J., Yi Y., Zhang H., Liu J., Liu M., et al. Induction of KLF4 in response to heat stress. Cell Stress Chaperones 11 (2006) 379-389
49. Moggs J.G., and Orphanides G. Genomic analysis of stress response genes. Toxicol Lett. 140-141 (2003) 149-153
50. Pirkkala L., Nykanen P., and Sistonen L. Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. FASEB J. 15 (2001) 1118-1131
51. Nickenig G., Baudler S., Muller C., Werner C., Werner N., Welzel H., et al. Redox-sensitive vascular smooth muscle cell proliferation is mediated by GKLF and Id3 in vitro and in vivo. FASEB J. 16 (2002) 1077-1086
52. Chen Z.Y., Shie J., and Tseng C. Up-regulation of gut-enriched kruppel-like factor by interferon-gamma in human colon carcinoma cells. FEBS Lett. 477 (2000) 67-72
53. Feinberg M.W., Cao Z., Wara A.K., Lebedeva M.A., Senbanerjee S., and Jain M.K. Kruppel-like factor 4 is a mediator of proinflammatory signaling in macrophages. J. Biol. Chem. 280 (2005) 38247-38258
54. Yoon H.S., Chen X., and Yang V.W. Kruppel-like factor 4 mediates p53-dependent G1/S cell cycle arrest in response to DNA damage. J. Biol. Chem. 278 (2003) 2101-2105
55. Ambros V. A hierarchy of regulatory genes controls a larva-to-adult developmental switch in C. elegans. Cell 57 (1989) 49-57
56. Wu L., and Belasco J.G. Micro-RNA regulation of the mammalian lin-28 gene during neuronal differentiation of embryonal carcinoma cells. Mol. Cell. Biol. 25 (2005) 9198-9208
57. Lin S.Y., Johnson S.M., Abraham M., Vella M.C., Pasquinelli A., Gamberi C., et al. The C elegans hunchback homolog, hbl-1, controls temporal patterning and is a probable microRNA target. Dev. Cell 4 (2003) 639-650
58. Niwa H., Burdon T., Chambers I., and Smith A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 12 (1998) 2048-2060
59. Kiuchi N., Nakajima K., Ichiba M., Fukada T., Narimatsu M., Mizuno K., et al. STAT3 is required for the gp130-mediated full activation of the c-myc gene. J. Exp. Med. 189 (1999) 63-73
60. Humphrey R.K., Beattie G.M., Lopez A.D., Bucay N., King C.C., Firpo M.T., et al. Maintenance of pluripotency in human embryonic stem cells is STAT3 independent. Stem Cells (Dayton, Ohio) 22 (2004) 522-530